Anthony Don Squeglia serves as Executive at Boston Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Anthony Don Squeglia has executed 1 insider transactions totaling $2.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 10, 2015 involved purchasing 10,000 shares valued at $2.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 10, 2015 | BTHE | $2.2K | Purchase | 10,000 | $0.22 | Discretionary |
Anthony Don Squeglia currently holds 128,350 shares of Boston Therapeutics, Inc. (BTHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Don Squeglia has been a net buyer of BTHE stock. They have purchased $2.2K and sold $0 worth of shares.
Anthony Don Squeglia's most recent insider trade was on Mar 10, 2015, when they purchased 10,000 shares at $0.22 per share.
Get notified when new Form 4 filings are submitted